New Investigator Salary Award: Fall 2008 Priority Announcement (Schizophrenia) - Funding Decisions Notification (September 2008 Competition: 200809MMS)

(Alternate Title: Michael Smith New Investigator for Research in Schizophrenia)

The Canadian Institutes of Health Research (CIHR) is pleased to announce the results New Investigator Salary Award: Fall 2008 Priority Announcement (Schizophrenia) competition.

Funding Opportunity Summary

In 1993, Dr. Michael Smith, received the Nobel Prize for Chemistry for his discovery and development of a crucial technique, known as site-directed mutagenesis, used in genetic engineering. His discovery enabled researchers to gain enormous insights into the structure and function of genes and proteins. Throughout his career, Dr. Smith strongly encouraged young people to pursue science as a career, and he has used his prize to promote science, encourage women to pursue interests in science and support research on severe mental illnesses, especially schizophrenia. To honor Dr. Smith's scientific accomplishments and his lifelong promotion of science, CIHR offers a New Investigator Salary Award in his name (CIHR Michael New Investigator Award for Research in Schizophrenia).

The recipient of the award will be the top ranked schizophrenia researcher as identified through the results of the September 2008 (2008-09) competition of the CIHR "New Investigator Salary Award: 2008-2009" program.

Funding Competition Summary

One award was approved for funding.

Contact Information

For further information about this competition, this initiative and the objectives of this funding opportunity please contact:

Christian Brochu
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-952-9873
Fax: 613-954-1800
Email: christian.brochu@cihr-irsc.gc.ca

Funding Decisions Data Report

Access the "Michael Smith New Investigator for Research in Schizophrenia" funding decisions data report.